Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

Coeptis Therapeutics Inc.

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-21Dec-31-20
   10-K10-K
Revenues:  
    Two Customers  0.1 
Revenues  0.10.0
            Revenue growth  143.8% 
Cost of goods sold  0.01.0
Gross profit  0.1-0.9
            Gross margin  100.0%-3034.5%
Selling, general and administrative   [+]14.15.8
Research and development   0.0
Other operating expenses  0.20.1
EBITDA   [+]-13.8-6.5
            EBITDA margin  -18380.9%-21254.1%
Depreciation  0.40.0
EBITA  -14.2-6.6
            EBITA margin  -18977.4%-21357.4%
Amortization of intangibles   0.3
EBIT   [+]-14.2-6.9
            EBIT margin  -18977.4%-22305.5%
Interest expense  0.20.1
Other income (expense), net   [+]1.0-2.1
Pre-tax income  -13.4-9.2
Income taxes  0.00.0
            Tax rate  0.0%0.0%
Net income  -13.4-9.2
            Net margin  -17932.4%-29765.9%
   
Basic EPS   [+]($0.42)($0.51)
Diluted EPS   [+]($0.42)($0.51)
   
Shares outstanding (basic)   [+]32.418.1
Shares outstanding (diluted)   [+]32.418.1
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy